CCND1 and prostate neoplasm: Similarly, others have shown low cyclin D1 gene amplification (4%) in primary prostate tumours (Gumbiner et al, 1999) and, depending on the method of detection, 5–15% gene amplification in advanced prostate tumours (Bubendorf et al, 1999; El Gedaily et al, 2001).